Cisbio has patented HTRF technology for the direct detection of total tau protein using a monoclonal antibody labeled with cryptate and a polyclonal antibody labeled with deuterium.
The HTRF MAP Tau kit provides the means to miniaturize the assay into 1536 format, a requirement for screening TRND compound libraries and maintain a signal to background ratio that fulfills the centers standard assay requirements.

In compliance with Federal Acquisition Regulation (FAR) 13.106-1(b) Soliciting from a single source. This notice of intent is not a request for competitive proposals, however; all responses received, before the closing date, of this announcement will be considered by the Government. A determination by the Government not to compete this proposed acquisition is based upon responses to this notice and is solely within the discretion of the Government. It is anticipated that the RFQ NIH-NICHD-17-293 will be available five (5) days after the publication date of this synopsis. Receipt of quotations will be due three (3) days after the release of the RFQ. All interested parties to this solicitation may request a copy of the RFQ package in writing to the attention of Ms. Patricia Haun at Eunice Kennedy Shriver National Institute Child Health and Human Development (NICHD), 6710B Rockledge Drive, Room 1159C, Bethesda, MD 20892 or via email [email protected]. All requests must contain offerors name, address, telephone number and fax number. Email addresses are encouraged but not mandatory